Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-009-0470-6.pdf
Reference49 articles.
1. Lawson DH, Gonzalez R, Weber RW, Hutchins LF, Anderson CM, Williams KN et al. (2008) 2-Year overall survival (OS) results of a phase II trial of elesclomol (formerly STA-4783) and paclitaxel in stage IV metastatic melanoma (MM). 2008 ASCO Annual Meeting. J Clin Oncol 26 (May 20 suppl): abstr 20023
2. Agarwala SS, Haddad J, Jacobson E (2008) Integrated safety analysis of elesclomol (formerly STA-4783) co-administered with paclitaxel. 2008 ASCO Annual Meeting. J Clin Oncol 26 (May 20 suppl): abstr14595
3. Tuma RS (2008) Reactive oxygen species may have anti-tumor activity in metastatic melanoma. J Natl Cancer Inst 100:11–12
4. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, Lillig CH (2005) Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 33:1375–1377
5. Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-08-16
2. Perturbation of Copper Homeostasis Sensitizes Cancer Cells to Elevated Temperature;International Journal of Molecular Sciences;2023-12-28
3. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications;Journal of Translational Medicine;2023-10-20
4. Establishment of a 7-gene expression panel to improve the prognosis classification of gastric cancer patients;Frontiers in Genetics;2023-09-12
5. Copper metabolism in cell death and autophagy;Autophagy;2023-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3